20 Participants Needed

TMS for Anorexia

AM
SG
Overseen BySasha Gorrell, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
Must be taking: Psychotropic medications
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial uses a type of brain stimulation called theta burst rTMS to treat adults with Anorexia Nervosa. The treatment targets a specific brain area involved in obsessive and compulsive behaviors. The goal is to reduce these symptoms and improve patients' eating habits. Theta burst stimulation (TBS) is a newer and more effective form of repetitive transcranial magnetic stimulation (rTMS) that has shown promise in treating neuropsychiatric disorders.

Will I have to stop taking my current medications?

No, you can continue taking your current medications as long as they have been stable for 4 weeks before the study and you agree to keep taking them throughout the study.

What data supports the effectiveness of the treatment Repetitive Transcranial Magnetic Stimulation (rTMS) for Anorexia?

Research shows that repetitive transcranial magnetic stimulation (rTMS) may help improve symptoms in people with severe anorexia, as seen in case studies where patients experienced changes in food choices and improvements in related conditions like depression.12345

Is repetitive transcranial magnetic stimulation (rTMS) safe for humans?

Repetitive transcranial magnetic stimulation (rTMS) has been shown to be safe and well-tolerated in clinical trials, including those involving people with obesity and anorexia nervosa.12678

How is repetitive transcranial magnetic stimulation (rTMS) different from other treatments for anorexia nervosa?

Repetitive transcranial magnetic stimulation (rTMS) is unique because it is a brain-directed treatment that uses magnetic fields to stimulate specific areas of the brain, such as the dorsolateral prefrontal cortex, which may help reduce symptoms of anorexia nervosa. Unlike traditional therapies, rTMS is non-invasive and does not involve medication, making it a novel option for those with treatment-resistant anorexia or comorbid conditions like depression.13479

Research Team

AM

Andrew M Lee, MD, PhD

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for outpatients aged 18-45 with Anorexia Nervosa (AN), stable on psychotropic meds for 4 weeks, and able to give informed consent. Excluded are those with schizophrenia, bipolar disorder, severe neurocognitive disorders, seizure disorders, metal in the head or certain implanted devices.

Inclusion Criteria

Meets DSM-5 criteria for AN
Ability to tolerate clinical study procedures
Successfully complete the screening forms without any contraindications
See 5 more

Exclusion Criteria

I am unable to commit to the full duration of the study.
I do not have any unstable health conditions like uncontrolled high blood pressure.
I do not have severe brain-related health issues like major memory problems, seizures, or brain lesions.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive five treatments of inhibitory continuous theta burst rTMS to the right orbitofrontal cortex every hour over the course of 10 days

2 weeks
Daily visits for 10 days

Follow-up

Participants are monitored for safety and effectiveness after treatment with assessments at 1 month and ongoing monthly evaluations for a year

12 months
Monthly visits

Treatment Details

Interventions

  • Repetitive Transcranial Magnetic Stimulation (rTMS)
Trial OverviewThe study tests if Repetitive Transcranial Magnetic Stimulation (rTMS) targeting the orbitofrontal cortex can help treat AN by reorganizing brain networks. Participants' responses will be monitored using functional magnetic resonance imaging (fMRI).
Participant Groups
1Treatment groups
Experimental Treatment
Group I: TMS (Aim 2)Experimental Treatment1 Intervention
Our protocol consists of five treatments of inhibitory continuous TBS (cTBS) to the R OFC lasting three minutes delivered every hour over the course of 10 days (2 weeks) for a total of 50 treatments.

Repetitive Transcranial Magnetic Stimulation (rTMS) is already approved in United States, European Union, Canada, Japan for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as rTMS for:
  • Depression
  • Smoking cessation
πŸ‡ͺπŸ‡Ί
Approved in European Union as rTMS for:
  • Depression
πŸ‡¨πŸ‡¦
Approved in Canada as rTMS for:
  • Depression
πŸ‡―πŸ‡΅
Approved in Japan as rTMS for:
  • Depression

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

Findings from Research

In a study involving two individuals with treatment-resistant anorexia nervosa, 19-20 sessions of high-frequency rTMS applied to the left dorsolateral prefrontal cortex led to improvements in eating disorder symptoms and mood.
The positive effects of rTMS were observed immediately after treatment and continued to improve at a one-month follow-up, indicating its potential as a promising adjunct treatment for anorexia nervosa.
Improvements in symptoms following neuronavigated repetitive transcranial magnetic stimulation (rTMS) in severe and enduring anorexia nervosa: findings from two case studies.McClelland, J., Bozhilova, N., Nestler, S., et al.[2018]
In a case series of five women with enduring anorexia nervosa, repetitive transcranial magnetic stimulation (rTMS) to the left dorsolateral prefrontal cortex led to significant improvements in eating disorder symptoms and mood after approximately 20 treatment sessions.
While initial improvements were noted, with some participants showing recovery at the 6-month follow-up, the benefits diminished by the 12-month follow-up, indicating the need for ongoing treatment or additional interventions.
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Enduring Anorexia Nervosa: A Case Series.McClelland, J., Kekic, M., Campbell, IC., et al.[2022]
In a pilot study involving 10 women with anorexia nervosa, high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) to the right dorsolateral prefrontal cortex (DLPFC) led to changes in food selection, indicating a potential therapeutic effect.
HF-rTMS was associated with increased healthiness ratings for both low- and high-fat foods and a greater selection of high-fat foods, suggesting that this stimulation may help reduce fat avoidance in individuals with anorexia nervosa.
Use of high-frequency repetitive transcranial magnetic stimulation to probe the neural circuitry of food choice in anorexia nervosa: A proof-of-concept study.Muratore, AF., Bershad, M., Steinglass, JE., et al.[2022]

References

Improvements in symptoms following neuronavigated repetitive transcranial magnetic stimulation (rTMS) in severe and enduring anorexia nervosa: findings from two case studies. [2018]
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Enduring Anorexia Nervosa: A Case Series. [2022]
Use of high-frequency repetitive transcranial magnetic stimulation to probe the neural circuitry of food choice in anorexia nervosa: A proof-of-concept study. [2022]
[Transcranial magnetic stimulation for comorbid depression in anorexia]. [2021]
Clinical outcomes and neural correlates of 20 sessions of repetitive transcranial magnetic stimulation in severe and enduring anorexia nervosa (the TIARA study): study protocol for a randomised controlled feasibility trial. [2022]
Safety and tolerability of repeated sessions of deep transcranial magnetic stimulation in obesity. [2021]
Repetitive transcranial magnetic stimulation in anorexia nervosa: a pilot study. [2022]
A pilot study exploring the effect of repetitive transcranial magnetic stimulation (rTMS) treatment on cerebral blood flow and its relation to clinical outcomes in severe enduring anorexia nervosa. [2021]
'My dad was like "it's your brain, what are you doing?"': Participant experiences of repetitive transcranial magnetic stimulation treatment in severe enduring anorexia nervosa. [2022]